Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1989 Jan;64(1):92–95. doi: 10.1136/adc.64.1.92

Production of interferon in respiratory syncytial virus bronchiolitis.

D Isaacs 1
PMCID: PMC1791825  PMID: 2923479

Abstract

Production of interferon alfa in vitro was significantly reduced during acute respiratory syncytial virus bronchiolitis but subsequently returned to normal. Nasopharyngeal and endotracheal interferon alfa were detected intermittently and in low concentrations. The degree of impairment of in vitro production and poor in vivo production of interferon alfa suggest the need for a therapeutic trial of nebulised or systemic interferon in acute bronchiolitis.

Full text

PDF
92

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chonmaitree T., Roberts N. J., Jr, Douglas R. G., Jr, Hall C. B., Simons R. L. Interferon production by human mononuclear leukocytes: differences between respiratory syncytial virus and influenza viruses. Infect Immun. 1981 Apr;32(1):300–303. doi: 10.1128/iai.32.1.300-303.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Court S. D. The definition of acute respiratory illnesses in children. Postgrad Med J. 1973 Nov;49(577):771–776. doi: 10.1136/pgmj.49.577.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Douglas R. M., Moore B. W., Miles H. B., Davies L. M., Graham N. M., Ryan P., Worswick D. A., Albrecht J. K. Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting. N Engl J Med. 1986 Jan 9;314(2):65–70. doi: 10.1056/NEJM198601093140201. [DOI] [PubMed] [Google Scholar]
  4. Greenberg S. B., Harmon M. W., Couch R. B., Johnson P. E., Wilson S. Z., Dacso C. C., Bloom K., Quarles J. Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus. J Infect Dis. 1982 Apr;145(4):542–546. doi: 10.1093/infdis/145.4.542. [DOI] [PubMed] [Google Scholar]
  5. Hall C. B., Douglas R. G., Jr, Simons R. L., Geiman J. M. Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. J Pediatr. 1978 Jul;93(1):28–32. doi: 10.1016/s0022-3476(78)80594-0. [DOI] [PubMed] [Google Scholar]
  6. Hall C. B., Geiman J. M., Biggar R., Kotok D. I., Hogan P. M., Douglas G. R., Jr Respiratory syncytial virus infections within families. N Engl J Med. 1976 Feb 19;294(8):414–419. doi: 10.1056/NEJM197602192940803. [DOI] [PubMed] [Google Scholar]
  7. Hayden F. G., Albrecht J. K., Kaiser D. L., Gwaltney J. M., Jr Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. N Engl J Med. 1986 Jan 9;314(2):71–75. doi: 10.1056/NEJM198601093140202. [DOI] [PubMed] [Google Scholar]
  8. Isaacs D., Bangham C. R., McMichael A. J. Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet. 1987 Oct 3;2(8562):769–771. doi: 10.1016/s0140-6736(87)92502-5. [DOI] [PubMed] [Google Scholar]
  9. Isaacs D. Ribavirin. Pediatrics. 1987 Feb;79(2):289–291. [PubMed] [Google Scholar]
  10. McIntosh K., Fishaut J. M. Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus. Prog Med Virol. 1980;26:94–118. [PubMed] [Google Scholar]
  11. McIntosh K. Interferon in nasal secretions from infants with viral respiratory tract infections. J Pediatr. 1978 Jul;93(1):33–36. doi: 10.1016/s0022-3476(78)80595-2. [DOI] [PubMed] [Google Scholar]
  12. McIntosh K., McQuillin J., Gardner P. S. Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection. Infect Immun. 1979 Feb;23(2):276–281. doi: 10.1128/iai.23.2.276-281.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mills J., 5th, Van Kirk J. E., Wright P. F., Chanock R. M. Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol. 1971 Jul;107(1):123–130. [PubMed] [Google Scholar]
  14. Moehring J. M., Forsyth B. R. The role of the interferon system in respiratory syncytial virus infections. Proc Soc Exp Biol Med. 1971 Dec;138(3):1009–1014. doi: 10.3181/00379727-138-36039. [DOI] [PubMed] [Google Scholar]
  15. Nandapalan N., Taylor C., Scott R., Toms G. L. Mammary immunity in mothers of infants with respiratory syncytial virus infection. J Med Virol. 1987 Jul;22(3):277–287. doi: 10.1002/jmv.1890220312. [DOI] [PubMed] [Google Scholar]
  16. Scott G. M., Tyrrell D. A. Interferon: therapeutic fact or fiction for the '80s? Br Med J. 1980 Jun 28;280(6231):1558–1562. doi: 10.1136/bmj.280.6231.1558. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES